Patient Oriented Innovative Nutrition Trial (POINT): precision use of multinutrients for ADHD in youth

The purpose of this research is to engage with patients, clinicians and decision makers ("stakeholders") to prioritize study outcomes and design an Innovative Clinical Trial (iCT) to investigate the use a multinutrient treatment for children and youth with ADHD. The trial to be design would compare multinutrients to current therapies such as stimulant medications, or see how whether nutrients would effect ADHD in conjunction with dietary modifications and/or behavioural therapies; This study builds upon the results of the Micronutrients for ADHD in Youth (MADDY) study and aligns with the SPOR-iCT funding. Thus, this research will build a comprehensive team of multidisciplinary researchers, diverse patient partners, multidisciplinary practitioners and decision makers to create a study with potential to impact practice and guidelines for children with ADHD. In addition to design an iCT, we will assess the feasibility of using electroencephalogram (EEG) technology as a novel and objective measure of brain waves in youth with ADHD. The Potential Impact of this research is informing and changing practice by improving treatment options and clinical knowledge for children with ADHD. Having patients, practitioners and decision makers invested in the research, we will find the most appropriate design for an iCT that is relevant to stakeholder priorities and catalyze options for treatments for children with ADHD.